Merck
CN
  • Synthesis and antihyperglycemic activity of novel N-acyl-2-arylethylamines and N-acyl-3-coumarylamines.

Synthesis and antihyperglycemic activity of novel N-acyl-2-arylethylamines and N-acyl-3-coumarylamines.

Bioorganic & medicinal chemistry letters (2008-03-21)
Atma P Dwivedi, Shailesh Kumar, Vandana Varshney, Amar B Singh, Arvind K Srivastava, Devi P Sahu
摘要

A series of novel N-acyl-2-arylethylamines and N-acyl-3-coumarylamines were synthesized and evaluated for their antihyperglycemic activity. Compounds 3g and 6d exhibited lowering of postprandial plasma glucose by 30.7%, 23.3% in SLM and 25.6%, 25.4% in STZ models respectively which is significant compared to metformin and glybenclamide. Other compounds exhibited moderate to good activity ranging from 19.5% to 32.8% in SLM and 3.26% to 25.4% in STZ models.

材料
货号
品牌
产品描述

Sigma-Aldrich
格列本脲, meets USP testing specifications